[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES413639A1 - Un procedimiento para la preparacion de un compuesto deri- vado de dopamina. - Google Patents

Un procedimiento para la preparacion de un compuesto deri- vado de dopamina.

Info

Publication number
ES413639A1
ES413639A1 ES413639A ES413639A ES413639A1 ES 413639 A1 ES413639 A1 ES 413639A1 ES 413639 A ES413639 A ES 413639A ES 413639 A ES413639 A ES 413639A ES 413639 A1 ES413639 A1 ES 413639A1
Authority
ES
Spain
Prior art keywords
hydrogen
radicals
methyl
methoxy
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES413639A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES413639(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES413639A1 publication Critical patent/ES413639A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES413639A 1972-04-12 1973-04-12 Un procedimiento para la preparacion de un compuesto deri- vado de dopamina. Expired ES413639A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (1)

Publication Number Publication Date
ES413639A1 true ES413639A1 (es) 1976-01-16

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
ES413639A Expired ES413639A1 (es) 1972-04-12 1973-04-12 Un procedimiento para la preparacion de un compuesto deri- vado de dopamina.

Country Status (31)

Country Link
JP (2) JPS5825656B2 (es)
KR (1) KR790000113B1 (es)
AR (1) AR203822A1 (es)
AT (1) AT323719B (es)
AU (1) AU472734B2 (es)
BE (1) BE798051A (es)
BG (1) BG23001A3 (es)
CA (1) CA1018188A (es)
CH (2) CH580563A5 (es)
CS (2) CS190448B2 (es)
CY (1) CY963A (es)
DD (1) DD107670B3 (es)
DE (1) DE2317710C2 (es)
DK (1) DK142750C (es)
ES (1) ES413639A1 (es)
FR (1) FR2182947B1 (es)
GB (1) GB1392674A (es)
HK (1) HK50178A (es)
HU (2) HU167597B (es)
IE (1) IE37511B1 (es)
IL (1) IL42016A (es)
KE (1) KE2870A (es)
MY (1) MY7800381A (es)
NL (1) NL174459C (es)
PH (1) PH11041A (es)
PL (2) PL94207B1 (es)
RO (2) RO70892A (es)
SE (1) SE399064B (es)
SU (1) SU496719A3 (es)
YU (2) YU36483B (es)
ZA (1) ZA732136B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (es) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
NO822514L (no) * 1981-07-22 1983-01-24 Syntex Inc Fremgangsmaate ved fremstilling av terapeutisk virksomme 2,5-substituerte pyrrolidinderivater
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (es) * 1989-12-18 1991-08-23
WO1992020645A1 (fr) * 1991-05-20 1992-11-26 Tsumura & Co. Analogues de phellodendrine et suppresseur d'allergie de type iv les contenant en tant qu'ingredients actifs
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
DE69404063T2 (de) * 1993-04-13 1998-01-22 Duphar Int Res Herstellung von Dobutamin Verbindungen
AU2003274605A1 (en) 2002-10-03 2004-04-23 Novaremed Ltd Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
EP1750691B1 (en) 2004-03-26 2016-08-10 Novaremed Ltd. Compounds for treatment of aids and other diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
AU2010278711A1 (en) 2009-07-31 2012-02-23 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
US20170197977A9 (en) * 2011-08-25 2017-07-13 Cognition Therapeutics, Inc. Compositions and methods for treating neurodegenerative disease
ES2721001T3 (es) 2014-01-31 2019-07-26 Cognition Therapeutics Inc Derivado de isoindolina, y composiciones y métodos para tratar una enfermedad neurodegenerativa
KR102614814B1 (ko) 2017-05-15 2023-12-20 카그니션 테라퓨틱스, 인코퍼레이티드 신경변성 질환 치료용 조성물
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实(湖南)医药科技有限公司 一种盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
KE2870A (en) 1978-09-01
NL174459B (nl) 1984-01-16
ZA732136B (en) 1974-03-27
PL94207B1 (es) 1977-07-30
PL90695B1 (es) 1977-01-31
CS190406B2 (en) 1979-05-31
AU472734B2 (en) 1976-06-03
HU166213B (es) 1975-02-28
PH11041A (en) 1977-10-25
CY963A (en) 1978-12-22
JPS497237A (es) 1974-01-22
FR2182947B1 (es) 1976-07-02
YU321279A (en) 1983-04-27
SE399064B (sv) 1978-01-30
JPS58131945A (ja) 1983-08-06
DE2317710A1 (de) 1973-10-18
RO70892A (ro) 1982-02-26
NL174459C (nl) 1984-06-18
BG23001A3 (bg) 1977-05-20
DE2317710C2 (de) 1983-08-04
JPS6221343B2 (es) 1987-05-12
DD107670A5 (de) 1974-08-12
IL42016A0 (en) 1973-06-29
JPS5825656B2 (ja) 1983-05-28
SU496719A3 (ru) 1975-12-25
CH580563A5 (es) 1976-10-15
DK142750B (da) 1981-01-12
CS190448B2 (en) 1979-05-31
GB1392674A (en) 1975-04-30
HK50178A (en) 1978-09-15
AU5438573A (en) 1974-10-17
NL7305097A (es) 1973-10-16
HU167597B (es) 1975-11-28
FR2182947A1 (es) 1973-12-14
BE798051A (fr) 1973-10-11
YU36483B (en) 1984-02-29
YU37113B (en) 1984-08-31
RO65105A (ro) 1980-01-15
YU97673A (en) 1982-02-25
IL42016A (en) 1976-05-31
MY7800381A (en) 1978-12-31
CH569691A5 (es) 1975-11-28
AT323719B (de) 1975-07-25
KR790000113B1 (en) 1979-03-20
AR203822A1 (es) 1975-10-31
CA1018188A (en) 1977-09-27
DD107670B3 (de) 1988-04-06
DK142750C (da) 1981-08-17
IE37511B1 (en) 1977-08-03

Similar Documents

Publication Publication Date Title
ES413639A1 (es) Un procedimiento para la preparacion de un compuesto deri- vado de dopamina.
ES456279A1 (es) Un procedimiento para preparar compuestos de cetofosfonato.
ES387016A1 (es) Un procedimiento para la preparacion de derivado de isoqui-nolina.
ES439909A1 (es) Procedimiento para la preparacion de derivados s-2-tiol-4,5-difeniloxazol.
ES447664A1 (es) Procedimiento de preparacion de derivados de cardenolidas.
ES405479A1 (es) Un procedimiento para la preparacion de derivados de benzo-diacepina.
ES421182A1 (es) Procedimiento para preparar 1-fenoxi-3-fenoxi-etilamino-2- propanoles.
ES419386A1 (es) Un procedimiento para la preparacion de nuevos derivados deindenopirrol.
ES378206A1 (es) Procedimiento para la preparacion de nuevos 2-amino-5-ni- trotiazoles.
ES418841A1 (es) Procedimiento para la obtencion de derivados del acido pi- ridin-3-acetico.
ES412068A1 (es) Un procedimiento para la preparacion de compuestos anaste- sicos locales.
ES364980A1 (es) Un metodo para preparar nuevos derivados de adamantano.
ES442612A1 (es) Procedimiento para la obtencion de nuevos derivados de iso- quinoleina.
ES461191A1 (es) Un procedimiento para la preparacion de nuevos derivados de arilcarboxamida.
ES472572A1 (es) Un procedimiento para la preparacion de derivados de morfi- nano 3-fenoxi-n-sustituidos levogiros
ES405080A1 (es) Procedimiento para la obtencion de derivados del carbinol.
ES402551A1 (es) Un procedimiento para la preparacion de derivados de pipe- razina.
ES405281A1 (es) Un procedimiento para preparar nuevos compuestos de cefa- losporina.
ES417269A1 (es) Procedimiento para preparar derivados de imidazolidinona.
ES410009A1 (es) Un procedimiento para la preparacion de derivados de acidos7-acilamino-3-cefem-4-carboxilicos 3-sustituidos.
ES366913A1 (es) Un procedimiento para la preparacion de ciclohexanos susti-tuidos terapeuticamente activos.
ES427622A1 (es) Procedimiento para la preparacion de 2-amino-bencil-aminas.
ES334733A1 (es) Procedimiento para preparar derivados de esteres de acido-5halobenzoicos.
ES379617A1 (es) Procedimiento para la preparacion de aminoacidos.
ES385679A1 (es) Un procedimiento para la preparacion de derivados de n-ari-lideno de compuestos de eritromicilamina.